ArticleMolecular medicine reports2017

miR‑30c suppresses prostate cancer survival by targeting the ASF/SF2 splicing factor oncoprotein.

Ya-Qiang Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.